金山科研平台，产品价格货期咨询微信：jinshanbio Source:Mouse myeloma cell line, NS0-derived, Lys35-Gly320, with a C-terminal 6-His tag Accession #:Q53XP7 N-terminal Sequence Analysis:Lys35 Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:32.0 kDa SDS-PAGE:57-75 kDa, reducing conditions Activity:Measured by the ability of the immobilized protein to support the adhesion of calcium ionophore treated human neutrophils.When 2 x 10⁵ cells/well are added to CEACAM-6 coated plates (10µg/mL, 100µL/well), 35-60%of the cells will adhere after 20minutes at 37°C. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: CEACAM-6/CD66c Long Name: Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 Aliases: CD66c; CEAL; NCA Entrez Gene IDs: 4680 (Human) Background: CEACAM-6

CEACAM-6, previously called nonspecific crossreacting antigen (NCA) or CD66c, is a highly glycosylated 90 kDa, 286 aa, GPI-linked membrane protein of the human CEACAM family within the immunoglobulin superfamily. CEACAM-6 is an intercellular adhesion molecule, forming homotypic and heterotypic bonds with CEACAM-1, -5 and -8. Mature human CEACAM-6 shares 84% and 85% aa identity with human CEACAMs 1 and 5 (CEA). It is expressed in azurophilic granules in cells of the granulocyte lineage, and in epithelia of various organs.